310454-53-6

Basic information

• Product Name: BENZYL ETHYL PIPERIDINE-1,3-DICARBOXYLATE
• Synonyms: CBZ-PIPERIDINE-3-CARBOXYLIC ACID ETHYL ESTER;BENZYL ETHYL PIPERIDINE-1,3-DICARBOXYLATE;Benzyl ethyl piperidine-1,3-dicarboxylate 97%;1-Benzyl 3-ethyl piperidine-1,3-dicarboxylate;1,3-Piperidinedicarboxylic acid, 3-ethyl 1-(phenylMethyl) ester;1-Cbz-piperidine-3-carboxylic acid ethyl ester;1-O-benzyl 3-O-ethyl piperidine-1,3-dicarboxylate
• CAS NO: 310454-53-6
• Molecular Formula: C₁₆H₂₁NO₄
• Molecular Weight: 291.34
• Mol File: 310454-53-6.mol
• Article Data: 10

Chemical Properties

• Boiling Point: 537.4°Cat760mmHg
• Flash Point: 259.3°C
• Appearance: /
• Density: 1.266g/cm³
• Vapor Pressure: 9.97E-07mmHg at 25°C
• Refractive Index: 1.533
• Storage Temp.: 2-8°C
• PKA: -2.45±0.40(Predicted)
• CAS DataBase Reference: BENZYL ETHYL PIPERIDINE-1,3-DICARBOXYLATE(CAS DataBase Reference)
• NIST Chemistry Reference: BENZYL ETHYL PIPERIDINE-1,3-DICARBOXYLATE(310454-53-6)
• EPA Substance Registry System: BENZYL ETHYL PIPERIDINE-1,3-DICARBOXYLATE(310454-53-6)

Safety Data

• Hazard Codes: Xi
• Hazardous Substances Data: 310454-53-6(Hazardous Substances Data)

Usage

General Description

Benzyl ethyl piperidine-1,3-dicarboxylate is a chemical compound that is used as a local anesthetic. It belongs to the class of piperidine-based compounds and acts by blocking the transmission of nerve impulses in the body, leading to a numbing or loss of sensation in the area where it is applied. Benzyl ethyl piperidine-1,3-dicarboxylate is commonly used in medical and dental procedures as a topical anesthetic to reduce pain and discomfort. It is also utilized in research and pharmaceutical applications due to its anesthetic properties. This chemical should be handled and used with care, following proper safety protocols and guidelines.

InChI:InChI=1/C16H21NO4/c1-2-20-15(18)14-9-6-10-17(11-14)16(19)21-12-13-7-4-3-5-8-13/h3-5,7-8,14H,2,6,9-12H2,1H3

Upstream product

• 50585-89-2 3-methoxycarbonylpiperidine 
• 501-53-1 benzyl chloroformate 
• 71962-74-8 Ethyl nipecotate 
• 78190-11-1 1-benzyloxycarbonylpiperidine-3-carboxylic acid 
• 75-03-6 ethyl iodide 

Downstream Products

• 174543-78-3 1-((benzyloxy)carbonyl)-3-methylpiperidine-3-carboxylic acid 
• 1196506-86-1 rac-benzyl 3-((tert-butoxycarbonyl)amino)-3-methylpiperidine-1-carboxylate 
• 169750-96-3 tert-butyl N-(3-methyl-3-piperidinyl)carbamate 
• 160706-61-6 (R)-N-Cbz-3-hydroxymethylpiperidine 
• 405061-52-1 N-Cbz-3-hydroxymethylpiperidine 
• 170843-43-3 3-methylpiperidine-3-carboxylic acid ethyl ester 
• 784080-46-2 3-(1H-imidazol-5-yl)piperidine 
• 1352654-87-5 benzyl 3-(1H-imidazol-5-yl)piperidine-1-carboxylate 
• 1352654-77-3 benzyl 3-(1H-imidazol-2-yl)piperidine-1-carboxylate 
• 201478-72-0 1-Benzyloxycarbonylpiperidine-3-carboxaldehyde 
• 39945-51-2 benzyl 3-(hydroxymethyl)-1-piperidinecarboxylate 
• 1313369-56-0 C₁₉H₂₅NO₆ 
• 1313369-58-2 C₁₅H₁₉NO₃ 
• 1313369-57-1 C₁₅H₂₁NO₄ 

Relevant articles and documents

DIAMINOCYCLOHEXANE COMPOUNDS AND USES THEREOF

The present invention provides compounds of Formula (I) or a stereo isomer, or a pharmaceutically acceptable salt thereof, wherein all of the variables are as defined herein. These compounds are agonists, partial agonists and modulators of the NPY Y4 rece

Carbazole inhibitors of histamine receptors for the treatment of disease

The present invention relates to carbazole compounds, pharmaceutical compositions comprising them, and methods which may be useful as inhibitors of H1R and/or H4R for the treatment or prevention of inflammatory, autoimmune, allergic, and ocular diseases.

SPIRO CYCLOPENTANE COMPOUNDS USEFUL AS ANTAGONISTS OF THE H1-RECEPTOR

This invention relates to novel spiro cyclopentane derivatives of formula (I) or a pharmaceutically acceptable salt thereof, for treating diseases and conditions of the central nervous system (CNS), in particular sleep disorders.